[Active immunotherapy with allogenic leukemic cells in complex treatment of patients with acute leukemia]. 1978

T I Riabova, and N V Riabov, and T V Gritsenko, and E P Svedentsov

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

T I Riabova, and N V Riabov, and T V Gritsenko, and E P Svedentsov
January 1977, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
T I Riabova, and N V Riabov, and T V Gritsenko, and E P Svedentsov
October 1994, Sangre,
T I Riabova, and N V Riabov, and T V Gritsenko, and E P Svedentsov
April 2006, International journal of oncology,
T I Riabova, and N V Riabov, and T V Gritsenko, and E P Svedentsov
January 2009, Terapevticheskii arkhiv,
T I Riabova, and N V Riabov, and T V Gritsenko, and E P Svedentsov
December 1978, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
T I Riabova, and N V Riabov, and T V Gritsenko, and E P Svedentsov
October 1977, Haematologica,
T I Riabova, and N V Riabov, and T V Gritsenko, and E P Svedentsov
August 2014, Leukemia,
T I Riabova, and N V Riabov, and T V Gritsenko, and E P Svedentsov
January 2003, Methods in molecular biology (Clifton, N.J.),
T I Riabova, and N V Riabov, and T V Gritsenko, and E P Svedentsov
May 1975, La Nouvelle presse medicale,
T I Riabova, and N V Riabov, and T V Gritsenko, and E P Svedentsov
December 2010, Drug metabolism letters,
Copied contents to your clipboard!